Research: Pomegranate Reduces the Risk of Alzheimer's and Parkinson's Disease

Press/Media: Research


Combating neurodegeneration — naturally 
It’s estimated that worldwide cases of dementia — a collection of illnesses that are extremely concerning due to their destructive nature and the lack of treatment options — will triple by 2050. 

Over the last several years, scientists have established that inflammation plays a key role in the development of these debilitating diseases. Now, a new study from the University of Huddersfield in the UK has shown that the compound punicalagin, a potent polyphenol present in pomegranates, significantly inhibits the inflammation of a type of glial cell — known as microglia — which are found throughout the brain.


“Dr. Olumayokun Olajide, a University researcher interested in the anti-inflammatory properties of natural products, led the research. He and his team ran tests of punicalagin on the cultured brain cells of rats. They looked at the interplay between the compound and any traces of inflammation found in the microglia. Parkinson’s disease, and to a lesser extent Alzheimer’s, relies on compounding inflammatory damage to destroy cells in a cascade.”

Period10 Jun 2017

Media coverage


Media coverage